Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Pasi Salmela"'
Autor:
Minna Koivikko, Tapani Ebeling, Markus Mäkinen, Juhani Leppäluoto, Antti Raappana, Petteri Ahtiainen, Pasi Salmela
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2022)
Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a lo
Externí odkaz:
https://doaj.org/article/d21c70b53df44a2784d0774907d18994
Autor:
Elina Peltola, Päivi Hannula, Heini Huhtala, Saara Metso, Ulla Kiviniemi, Martine Vornanen, Juhani Sand, Johanna Laukkarinen, Mirja Tiikkainen, Camilla Schalin-Jäntti, Johanna Arola, Jukka Sirén, Antti Piiroinen, Minna Soinio, Pirjo Nuutila, Mirva Söderström, Hanna Hämäläinen, Leena Moilanen, David Laaksonen, Elina Pirinen, Fia Sundelin, Tapani Ebeling, Pasi Salmela, Markus J. Mäkinen, Pia Jaatinen
Publikováno v:
International Journal of Endocrinology, Vol 2018 (2018)
Objective. Insulinomas are rare pancreatic tumours. Population-based data on their incidence, clinical picture, diagnosis, and treatment are almost nonexistent. The aim of this study was to clarify these aspects in a nationwide cohort of insulinoma p
Externí odkaz:
https://doaj.org/article/bd23361b5b8040b39a0ae372dac907e2
Autor:
Iina Yliaska, Heikki Tokola, Tapani Ebeling, Outi Kuismin, Olavi Ukkola, Minna L. Koivikko, Timo Lesonen, Jussi Rimpiläinen, Tuuli Felin, Eeva Ryhänen, Saara Metso, Camilla Schalin-Jäntti, Pasi Salmela
Publikováno v:
Endocrine. 77(3)
Objective MEN1 is associated with an increased risk of developing tumors in different endocrine organs. Neuroendocrine tumors of the thymus (TNETs) are very rare but often have an aggressive nature. We evaluated patients with MEN1 and TNET in three u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6950e171c2ca6125abeb20562a3cb2b9
https://pubmed.ncbi.nlm.nih.gov/35696052
https://pubmed.ncbi.nlm.nih.gov/35696052
Autor:
Minna Koivikko, Tapani Ebeling, Markus Mäkinen, Juhani Leppäluoto, Antti Raappana, Petteri Ahtiainen, Pasi Salmela
Publikováno v:
Endocrinology, diabetesmetabolism case reports. 2022
Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f79342181b915655a7e63f3002b826a2
https://pubmed.ncbi.nlm.nih.gov/35199646
https://pubmed.ncbi.nlm.nih.gov/35199646
Autor:
Pasi, Salmela, Saara, Metso, Leena, Moilanen, Leo, Niskanen, Pirjo, Nuutila, Camilla, Schalin-Jäntti
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 132(1)
The diagnosis of hypothyroidism is based on the findings of an increased serum TSH (above the reference range) and decreased serum free T4 (below the reference range) concentration. Treatment of subclinical hypothyroidism is indicated if serum THS is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88d7f0fff648b5f9f9151bf20afdafa0
https://pubmed.ncbi.nlm.nih.gov/27044179
https://pubmed.ncbi.nlm.nih.gov/27044179
Autor:
Matti, Välimäki, Esko, Alhava, Hannu, Aro, Kerttu, Irjala, Ari, Heinonen, Erkki, Hirvonen, Pekka, Jousilahti, Jorma, Komulainen, Heikki, Kröger, Christel, Lamberg-Allardt, Antti, Malmivaara, Kimmo, Mattila, Eero, Mervaala, Timo, Möttönen, Pasi, Salmela, Jorma, Salmi, Kari, Salovaara, Annikki, Savolainen, Harri, Suominen, Marjo, Tuppurainen, Jorma, Viikari
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 123(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c37c67fb174c2d7736fecca013e9a50e
https://pubmed.ncbi.nlm.nih.gov/17763654
https://pubmed.ncbi.nlm.nih.gov/17763654
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 118(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf9046dd234e51a70390516adc11bfc3
https://pubmed.ncbi.nlm.nih.gov/12271607
https://pubmed.ncbi.nlm.nih.gov/12271607
Autor:
L. Y. Dirix, A. M. Prove, H. Fierens, A. T. van Oosterom, Matti Välimäki, Heikki Järvinen, Pasi Salmela, Timo Sane, Sini-Marja Sjöblom, Risto Pelkonen
Publikováno v:
Cancer. 68:922-922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb7c8fae2b625e39c7ae75c92ad10270
https://doi.org/10.1002/1097-0142(19910815)68:4<922::aid-cncr2820680441>3.0.co
https://doi.org/10.1002/1097-0142(19910815)68:4<922::aid-cncr2820680441>3.0.co
Publikováno v:
European Radiology; May1992, Vol. 2 Issue 3, p194-198, 5p
Autor:
Pauli Pörsti, Markku Huttunen, Pasi Salmela, Markku Saraste, M. Heikki Frick, Timo Pitkäjärvi, Pekka Reinikainen, M.-L. Pyykönen, Lauri Pöyhönen, David A. Cox, Pertti Himanen
Publikováno v:
The American Journal of Cardiology. 59:G61-G67
Proatherogenic changes in serum lipid concentrations have been implicated as one of the major risk factors in the development of coronary artery disease. In a double-blind study, the new alpha 1-adrenoceptor inhibitor, doxazosin, was compared with at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abb378e1cf5c1e859eef3c385e0e7eb
https://doi.org/10.1016/0002-9149(87)90159-7
https://doi.org/10.1016/0002-9149(87)90159-7